ADAR1 Capital Management, LLC

KROS

ADAR1 Capital Management, LLC serves as 10 percent owner at Keros Therapeutics, Inc. (KROS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

11 trades

$20.20M

Total Sells

1 trades

$95.66M

Net Position

Net Seller

$75.46M

Companies Traded

TENX, NXTC, RLYB, KROS

Active Period

Aug 2024 – Sep 2026

12 total trades

Most Recent

Buy TENX

Sep 8, 2026 · $1.60M

ADAR1 Capital Management, LLC's Insider Trading at Keros Therapeutics, Inc. (KROS)

Buys

1 · $9.46M

Sells

1 · $95.66M

Total Shares Bought

934,258

Total Shares Sold

5,389,264

KROS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 15, 2025	Sell	5,389,264	$17.75	$95.66M	0
Apr 11, 2025	Buy	934,258	$10.13	$9.46M	4,392,737

ADAR1 Capital Management, LLC's Insider Trading at Tenax Therapeutics, Inc. (TENX)

Buys

3 · $4.80M

Sells

0 · $0.00

Total Shares Bought

2,696,200

Total Shares Sold

TENX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 8, 2026	Buy	900,000	$1.78	$1.60M	6,524,151
Sep 2, 2026	Buy	770,333	$1.79	$1.38M	5,624,151
Aug 24, 2026	Buy	1,025,867	$1.77	$1.81M	4,853,818

ADAR1 Capital Management, LLC's Insider Trading at Rallybio Corporation (RLYB)

Buys

4 · $4.23M

Sells

0 · $0.00

Total Shares Bought

302,473

Total Shares Sold

RLYB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 20, 2026	Buy	16,209	$13.98	$226.6K	926,352
May 15, 2026	Buy	79,559	$13.99	$1.11M	910,143
May 13, 2026	Buy	50,800	$14.00	$711.1K	830,584
May 6, 2026	Buy	155,905	$13.97	$2.18M	779,784

ADAR1 Capital Management, LLC's Insider Trading at NextCure, Inc. (NXTC)

Buys

2 · $1.61M

Sells

0 · $0.00

Total Shares Bought

326,761

Total Shares Sold

NXTC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 3, 2026	Buy	309,153	$4.93	$1.52M	722,419
Jul 29, 2026	Buy	17,608	$4.98	$87.7K	393,266

ADAR1 Capital Management, LLC's Insider Trading at Palvella Therapeutics, Inc. (PVLA)

Buys

1 · $92.3K

Sells

0 · $0.00

Total Shares Bought

6,000

Total Shares Sold

PVLA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 12, 2024	Buy	6,000	$15.39	$92.3K	129,574

Related Insiders

STAAB THOMAS R II

officer: Chief Financial Officer

TENXBuy · Sep 15, 2026

Christopher Thomas Giordano

director, officer: CEO

TENXBuy · Sep 15, 2026

Simcere Zaiming, Inc.

other: Former 10% Owner

NXTCSell · Aug 12, 2026

Jonathan I Lieber

Chief Financial Officer

RLYBSell · Feb 18, 2026

Stuart Rich

Chief Medical Officer

TENXBuy · Dec 8, 2025

MCGAULEY THOMAS

Interim CFO

TENXBuy · Nov 17, 2025

June Sherie Almenoff

Director

TENXBuy · Nov 17, 2025

Explore More Insider Trading Data

KROS Insider Trading Activity

View all insider trades at Keros Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity